tiprankstipranks
Immuneering to present data from Phase 2a trial of IMM-1-104 in early January
PremiumThe FlyImmuneering to present data from Phase 2a trial of IMM-1-104 in early January
2M ago
Immuneering downgraded to Underweight from Equal Weight at Morgan Stanley
Premium
The Fly
Immuneering downgraded to Underweight from Equal Weight at Morgan Stanley
2M ago
Immuneering granted FDA Fast Track designation for IMM-1-104
Premium
The Fly
Immuneering granted FDA Fast Track designation for IMM-1-104
2M ago
3 Penny Stocks to Watch Now, 9/18/24
PremiumMarket News3 Penny Stocks to Watch Now, 9/18/24
5M ago
Morning Movers: Boeing slips following Seattle factory workers’ strike
Premium
The Fly
Morning Movers: Boeing slips following Seattle factory workers’ strike
5M ago
Immuneering price target raised to $13 from $12 at Chardan
Premium
The Fly
Immuneering price target raised to $13 from $12 at Chardan
5M ago
Immuneering presents preclinical data on IMM-1-104 at AACR 2024
PremiumThe FlyImmuneering presents preclinical data on IMM-1-104 at AACR 2024
11M ago
Immuneering price target lowered to $8 from $20 at Mizuho
Premium
The Fly
Immuneering price target lowered to $8 from $20 at Mizuho
11M ago
Immuneering announces first patient dosed in Phase 1/2 trial of IMM-6-415
Premium
The Fly
Immuneering announces first patient dosed in Phase 1/2 trial of IMM-6-415
11M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100